A deterministic history of records added to PeptideScanner and preserved profile or record revisions connected through the reviewed Difelikefalin identity.
Showing the latest 24 additions by PeptideScanner publication date; the complete connected record set remains available on the cross-source timeline. Most recent addition: November 15, 2026.
PeptideScanner retained ClinicalTrials.gov record NCT03422653 at 2026-11-15T21:56:33.343Z. Its registry update date was 2022-04-26, and PeptideScanner's reviewed identity mapping was difelikefalin.
PeptideScanner retained ClinicalTrials.gov record NCT03617536 at 2026-11-15T21:56:33.343Z. Its registry update date was 2024-01-24, and PeptideScanner's reviewed identity mapping was difelikefalin.
PeptideScanner retained ClinicalTrials.gov record NCT03636269 at 2026-11-15T21:56:33.343Z. Its registry update date was 2022-04-26, and PeptideScanner's reviewed identity mapping was difelikefalin.
PeptideScanner retained ClinicalTrials.gov record NCT03998163 at 2026-11-15T21:56:33.343Z. Its registry update date was 2021-10-15, and PeptideScanner's reviewed identity mapping was difelikefalin.
PeptideScanner retained ClinicalTrials.gov record NCT05533008 at 2026-11-15T21:56:33.343Z. Its registry update date was 2022-09-08, and PeptideScanner's reviewed identity mapping was difelikefalin.
PeptideScanner retained ClinicalTrials.gov record NCT06593392 at 2026-11-15T21:56:33.343Z. Its registry update date was 2026-10-23, and PeptideScanner's reviewed identity mapping was difelikefalin.
The official Drugs@FDA dataset lists original submission 1 for ANDA 220919 with status AP dated 2026-08-31, and names difelikefalin acetate among the application record's active ingredients.
The official Drugs@FDA dataset lists original submission 1 for NDA 214916 with status AP dated 2021-08-23, and names difelikefalin acetate among the application record's active ingredients.
The Federal Register published notice 2023-10710, attributed to FDA and its parent HHS department, on 2023-05-19. Its official title is “Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Difelikefalin.
The Federal Register published notice 2023-26106, attributed to FDA and its parent HHS department, on 2023-11-28. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; Korsuva,” and PeptideScanner's exact reviewed identity mapping connects the document to Difelikefalin.
PubMed lists PMID 31702883 in The New England journal of medicine as Clinical Trial, Phase III, Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, and 1 more PubMed publication type, with publication-date metadata of 2019-11-08 (day precision). PeptideScanner associated the retained record with the identity slug difelikefalin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
PubMed lists PMID 31940704 in The New England journal of medicine as Editorial, Comment, with publication-date metadata of 2020-01-16 (day precision). PeptideScanner associated the retained record with the identity slug difelikefalin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
PubMed lists PMID 32433845 in The New England journal of medicine as Letter, Comment, with publication-date metadata of 2020-05-21 (day precision). PeptideScanner associated the retained record with the identity slug difelikefalin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
PubMed lists PMID 32433846 in The New England journal of medicine as Letter, Comment, with publication-date metadata of 2020-05-21 (day precision). PeptideScanner associated the retained record with the identity slug difelikefalin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
PubMed lists PMID 32433847 in The New England journal of medicine as Letter, Comment, with publication-date metadata of 2020-05-21 (day precision). PeptideScanner associated the retained record with the identity slug difelikefalin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
PubMed lists PMID 32433848 in The New England journal of medicine as Letter, Comment, with publication-date metadata of 2020-05-21 (day precision). PeptideScanner associated the retained record with the identity slug difelikefalin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
PubMed lists PMID 33190563 in Expert opinion on pharmacotherapy as Journal Article, Review, with publication-date metadata of 2020-12-14 (day precision). PeptideScanner associated the retained record with the identity slug difelikefalin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
PubMed lists PMID 34849553 in American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists as Journal Article, with publication-date metadata of 2022-01-01 (day precision). PeptideScanner associated the retained record with the identity slug difelikefalin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
PubMed lists PMID 35337427 in The Senior care pharmacist as Journal Article, with publication-date metadata of 2022-04-01 (day precision). PeptideScanner associated the retained record with the identity slug difelikefalin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
PubMed lists PMID 36780675 in The New England journal of medicine as Randomized Controlled Trial, Clinical Trial, Phase II, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2023-02-09 (day precision). PeptideScanner associated the retained record with the identity slug difelikefalin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
PubMed lists PMID 38253036 in American journal of nephrology as Clinical Trial, Phase III, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2024-01-22 (day precision). PeptideScanner associated the retained record with the identity slug difelikefalin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
PubMed lists PMID 38320524 in NEJM evidence as Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2023-10-17 (day precision). PeptideScanner associated the retained record with the identity slug difelikefalin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
PubMed lists PMID 39037824 in Kidney360 as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2024-07-22 (day precision). PeptideScanner associated the retained record with the identity slug difelikefalin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
PubMed lists PMID 39712488 in Frontiers in pharmacology as Journal Article, Systematic Review, with publication-date metadata of 2024-12-06 (day precision). PeptideScanner associated the retained record with the identity slug difelikefalin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.